Skip to main content
. 2019 Dec 28;9(1):81. doi: 10.3390/cells9010081

Figure 6.

Figure 6

Evaluation of astrocyte activation by GFAP immunohistochemistry after 6 weeks of cuprizone treatment (a) Representative images of control (CTRL) and cuprizone-treated (CU) groups in GFAP-Cre−/− TRPA1Fl/Fl, GFAP-Cre+/− TRPA1Fl/− and GFAP-Cre+/− TRPA1Fl/Fl mice.; (b) Pixel intensities of diaminobenzidine staining in the middle part of the corpus callosum in each group; *p < 0.05, n = 3–5/group, Scale bar = 100 µm.